Skip to content
  • Spain
  • United Kingdom
  • Europe
  • United States
  • Japan
  • The Middle East
  • Brazil
  • Italy
  • Canada
  • India
  • China
  • Taiwan
  • Mexico
  • Perú
  • Russia
  • Chile
  • Argentina
  • Turkey
  • Middle East
    موقعك
  • Request Information 800 50342
    طلب معلومات 800 50342
  • Languages
    • You need Polylang or WPML plugin for this to work. You can remove it from Theme Options.
  • Request Information 800 50342
    طلب معلومات 800 50342
Middle EastMiddle East
  • We guide you
    • Fertility
    • Inherited diseases
    • Worry-free pregnancy
  • Reproductive Health
    • For Health Specialists
    • For Patients
  • Diagnostics
  • About us
    • Research & Igenomix Foundation
    • About Igenomix
  • COVID-19 WEBINARS
Our Services > WES

WES Whole Exome Sequencing

A complete DNA test to identify mutations in over 24,000 genes related to complex genetic problems

  • Overview
  • Features
  • How does it Work?
  • I’m a health specialist

Information obtained from DNA that has over 24,000 genes

+14.000 clinical exomes since 2015

Advanced NGS technology

Quality reporting

Overview

What are genetic diseases?

Genetic diseases are caused by mutations – changes to our genes. Mutations associated with recessive genetic disease can be present in DNA without affecting the individual – they are a carrier of the condition. 82% of individuals are carriers of at least one condition.

What is WES?

  • A complete genetic test that look for alterations in the DNA sequence within over 24,000 genes in complex genetic disorder cases.
  • Examines a wider panel of genes that are responsible for the most complex health conditions.
  • WES reaches the end of the line for diagnostic options, with no other tests that could be offered.
  • Classifies information obtained from DNA that has over 24,000 genes.
Features
  • Benefits
  • Indications

Why use WES?

An exome sequencing study can identify:

  • Numerous mutations or changes in the DNA that can result in an affected child in the patient’s family.
  • The main indication of exome sequencing is to characterize an unmapped monogenic genetic disease present in a descendant, recognized as an index patient.
  • The WES test aims to identify a mutation that explains the symptoms associated with a typically hereditary disease.

Is WES for you?

This test is suitable in case of:

  • For any couple who wants to know the risk of transmitting hereditary genetic disorders to their children.
  • Before an assisted reproductive treatment (ART) to understand the mutations in the DNA that can lead to affected child.
  • For couples who have already undergone some genetic testing and is looking for the most extensive genetic tests..
  • WES may find a genetic cause for your or your child’s signs and symptoms even if previous genetic testing did not.
  • Individuals with genetic disorders known to have multiple associated genes, or multiple number of clinical signs and symptoms.
How does it work?

BROCHURE

Download
email

  • Request for Genetic counseling Session

  • *

  • Do you have any questions?

  • *

Other services you may be interested

PGT-M

Prevents the transmission of single gene disorders

More information

ERA

Avoid implantation failure by establishing the best day and time for embryo transfer

More information

CGT

Determines the risk of having a child with a genetic disease

More information

Igenomix is in the media

IGENOMIX has not affiliated any news outlet or publication identified above. News coverage does not constitute an endorsement of IGENOMIX or its products

WE GUIDE YOU

Fertility

Inherited diseases prevention

Healthy pregnancy

OUR SERVICES

Genetic solutions
For Patients
How to send a sample?
User manual

ABOUT US

About Igenomix

Contact

Press and news

Quality

Work with us

FOLLOW IGENOMIX

Blog: Path to fertility

  800 50342
  Write us
  • Spain
  • United Kingdom
  • Europe
  • United States
  • Japan
  • The Middle East
  • Brazil
  • Italy
  • Canada
  • India
  • China
  • Taiwan
  • Mexico
  • Perú
  • Russia
  • Chile
  • Argentina
  • Turkey
Language

[2019] © Igenomix Privacy policy Quality policy Legal note Cookies policy

Request Information


Download ERA eBook

Download EMMA eBook

Download ALICE eBook

Download NACE eBook

Download EndomeTRIO eBook

Download PGT-A eBook

Download POC eBook

Download SAT eBook

Download Oncodona eBook

Download Baby Gender eBook

Download WES eBook

Download PGT-M Brochure eBook

Download PGT-M Full Disease List eBook

Download WES Technical Sheet

Download WES eBook

Download WES Instructions eBook

Download SAT Clinical Sheets eBook

Download SAT Instructions eBook

Download Oncodona Brochure eBook

Download Oncodona Instructions eBook

Download PGT-A Technical Sheets eBook

Download PGT-A Brochure eBook

Download PGT-A Mitoscore eBook

Download PGT-A Instructions eBook

Download PGT-M Brochure eBook

Download PGT-M Technical Sheets eBook

Download PGT-M Instructions eBook

Download Baby Gender Step Guide eBook

Download Baby Gender Brochure eBook

Download ERA Technical Sheets eBook

Download ERA Brochure eBook

Download ERA Instructions eBook

Download ERA Instructions eBook

Download EMBRACE Clinical Sheets eBook

Download EMBRACE Brochure eBook

Download EMMA Technical Sheets eBook

Download EMMA Brochure eBook

Download EMMA Instructions eBook

Download ALICE Technical Brochure eBook

Download ALICE FAQ eBook

Download ALICE Infographic Brochure eBook

Download ALICE Brochure eBook

Download ALICE Instructions eBook

Download EndomeTRIO Clinical Sheets eBook

Download EndomeTRIO Brochure eBook

Download EndomeTRIO Infography eBook

Download EndomeTRIO Manual eBook